Form 4: Gossamer Bio Director Receives Stock Option Grant

Director Russell J. Cox was granted 115,000 stock options as part of the Gossamer Bio, Inc. non-employee director compensation program.

Summary

• Russell J. Cox, a director at Gossamer Bio, Inc., was granted 115,000 stock options on June 4, 2026.
• The options have an exercise price of $0.178 per share.
• The options are set to expire on June 3, 2036.
• The grant is part of the company's standard non-employee director compensation program.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

• Market volatility affecting the value of the granted options.
• Vesting is contingent upon continued service on the board of directors.

Future Outlook

The options vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, provided the director remains in service.

Management Comments

• The award was made pursuant to the company's Non-Employee Director Compensation Program.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure board members are incentivized to drive long-term shareholder value.

Comparison to Industry Standards

• The use of annual equity grants for board members is consistent with standard compensation practices for mid-cap and small-cap biotech firms.
• The vesting schedule tied to the next annual meeting is a common retention mechanism in the industry.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options on the first anniversary of the grant or the next annual meeting of stockholders.

Key Dates

Keywords

Gossamer Bio, GOSS, Form 4, Director Compensation, Stock Options, Insider Trading